The Worldwide Precision Medicine Industry is Expected to Reach $100 Billion by 2026
News provided by
Share this article
Share this article
ResearchAndMarkets.com s offering.
The precision medicine market is evaluated at US$60.422 billion for the year 2020 growing at a CAGR of 8.79% reaching the market size of US$100.168 billion by the year 2026.
Increasing Chronic Diseases
The market is expected to be driven by the growth and surge in several chronic diseases such as cardiovascular diseases, obesity, and other related diseases. According to the World Health Organization, Cardiovascular diseases are one of the major causes of deaths, globally, every year. In 2016, an approx. 17.9 million people died from cardiovascular diseases, which represented approx. 31% of global deaths. Most of these deaths were due to different types of strokes and heart attacks. Precision Medicines have been quickly moving towards real-world clinical features, and various scientific and research organi
Precision Oncology Market Share & Trends, CAGR of 9 9%, By End-User, By Technology, And Forecasts To 2027
texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.
Integra Connect Welcomes New COO
Integra Connect announces Cory Wiegert as new COO to provide strategic leadership as company expands, rebrands and focuses on growth opportunities to fight cancer.
News provided by
Share this article
Share this article
WEST PALM BEACH, Fla., Jan. 14, 2021 /PRNewswire/ Integra Connect, the leading provider of technologies and services for value-based specialty care and precision oncology, today announces the addition of Cory Wiegert as its new Chief Operating Officer (COO) to provide strategic leadership as the company expands with its integrated solutions for Precision Oncology, Population Health, Cloud EHR and Revenue Cycle management.
Cory Wiegert comes to Integra Connect from his previous role as Chief Executive Officer of CancerLinQ, LLC, and Executive Vice President of ASCO. Mr. Wiegert previously served as Vice President of Product Management for IBM Watson Health, leading the launch of major products, including IBM s cloud-based of
Exact Sciences Announces Preliminary Fourth Quarter 2020 Results
- Expected total revenue of $464.5-467.5M, including Screening revenue of $249-250M, Precision Oncology revenue of $117-118M, and COVID-19 testing revenue of $98.5-99.5M
News provided by
Share this article
Share this article
MADISON, Wis., Jan. 10, 2021 /PRNewswire/ Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company expects to report revenue between $464.5 million and $467.5 million for the fourth quarter ended Dec. 31, 2020. I m incredibly proud of how the Exact Sciences team came together during 2020 to make progress towards our mission of eradicating cancer and the suffering it causes, said Kevin Conroy, chairman and CEO of Exact Sciences. Following our combination with Thrive, we are confident in making blood-based, multi-cancer screening a reality and being a leading provider of earlier, smarter cancer tests for patients at every step of their journey. We ve never been more excited abo
vimarsana © 2020. All Rights Reserved.